TROCOXIL 6MG CHEWABLE TABLETS FOR DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

MAVACOXIB

Available from:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

mavacoxib(6mg/Tb)

Pharmaceutical form:

ORAL TABLET

Composition:

MAVACOXIB UNGROUPED Active 6.0 mg/Tb

Units in package:

2 tablets

Class:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

Therapeutic group:

DOG | BITCH | CASTRATE | PUPPY

Therapeutic area:

ANALGESIC+MUSCULOSKELETAL

Therapeutic indications:

MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE

Product summary:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [MUSCULOSKELETAL CONDITIONS]; For the treatment of pain & inflammation associated with degenerative joint disease in dogs.NOT TO BE USED in food producing species of animals. See Contraindications section on product leaflet.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Info
PEST


Verified

Summary of Product characteristics

PRODUCT NAME: TROCOXIL
PAGE: 1 OF 5
THIS REVISION ISSUED: AUGUST, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Mavacoxib is a non-steroidal anti-inflammatory drug:-
4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide.
TRADE NAME:
TROCOXIL
PRODUCT USE:
Veterinary product used as non-steroidal, anti-inflammatory drug
(NSAID).
CREATION DATE:
JUNE, 2011
THIS VERSION ISSUED:
AUGUST, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Xn, Harmful. N, Dangerous to the environment. Not classified as
hazardous according
to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R52/53. Harmful to aquatic organisms, may cause long-term adverse
effects to the aquatic
environment. T;R61 (Repr.Cat.2) May cause harm to the unborn child.
Xn;R48/22 Danger of serious damage to
health by prolonged oral exposure.
SAFETY PHRASES:
S22, S25, S61. Do not breathe dust. Avoid contact with eyes. Avoid
release to the environment.
Refer to special instructions/Safety Data Sheets.
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Brown tablets.
ODOUR:
Odour of cooked meat.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
a physiologically active
product and so contact should be minimised, especially if the user is
taking a form of medicat